Department of Nutritional Sciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas, USA.
Department of Medicine, New York University Grossman Medical Center, New York, New York, USA.
Pediatr Obes. 2022 Oct;17(10):e12925. doi: 10.1111/ijpo.12925. Epub 2022 May 12.
Pediatric MetS prevalence varies due to lack of consensus on evaluative criteria and associated thresholds, with most not recommending a diagnosis <10 years. However, MetS risk components are becoming evident earlier in life and affect races and ethnicities disproportionately.
To compare the prevalence of MetS based on existing definitions and elucidate racial- and ethnic-specific characteristics associated with MetS prevalence.
The baseline and follow-up samples included 900 and 557 children 7-10 years, respectively. Waist circumference, BMI percentile, blood pressure, fasting plasma glucose (FPG), insulin, triglycerides, and high-density lipoprotein cholesterol (HDL-C) were measured. Agreement between MetS definitions was quantified via kappa statistics. MetS and risk factor prevalence and the predictability of metabolic parameters on MetS eight months later was evaluated via logistic regression. McFadden pseudo-R2 was reported as a measure of predictive ability, and the Akaike information criterion evaluated fit of each model.
The baseline sample was 55.0% male and 71.6% Hispanic, followed by non-Hispanic White (NHW) (17.3%) and non-Hispanic Black (NHB) (11.1%), with an average age of 9.2 years. MetS prevalence ranged from 7.6% to 21.4%, highest in Hispanic (9.0%-24.0%) and lowest in NHB children (4.0%-14.0%). Highest agreement was between Ford et al. and Cook et al. definitions (K = 0.88) and lowest agreements were consistently with the International Diabetes Federation criteria (K ≤ 0.57). Compared to NHW children, Hispanic children had higher odds for MetS (OR: 1.7; p = 0.03) and waist circumference, HDL-C, and FPG risk factors (p < 0.05), while NHB children had higher odds for the FPG risk factor (p ≤ 0.007) and lower odds for the plasma triglycerides risk factor (p = 0.002), across multiple MetS definitions. In longitudinal analyses, HDL-C was the strongest independent predictor of MetS in Hispanic and NHW children (p < 0.001 and p < 0.01, respectively), while plasma triglycerides was the strongest independent predictor of MetS in NHB children (p < 0.05).
MetS prevalence was high in children ≤10 years, and proposed criteria are susceptible to racial and ethnic bias, diagnosing some populations more than other populations with high cardiovascular risk. Earlier preventative measures should be imposed in clinical settings, accounting for racial and ethnic differences, to mitigate disease onset.
由于缺乏评估标准和相关阈值的共识,儿科代谢综合征(MetS)的患病率存在差异,大多数标准不建议在<10 岁时做出诊断。然而,代谢综合征的风险因素在生命早期就变得明显,并且对不同种族和民族的影响不均衡。
比较基于现有定义的代谢综合征患病率,并阐明与代谢综合征患病率相关的种族和民族特异性特征。
基线和随访样本分别包括 900 名和 557 名 7-10 岁的儿童。测量腰围、BMI 百分位数、血压、空腹血糖(FPG)、胰岛素、甘油三酯和高密度脂蛋白胆固醇(HDL-C)。通过 Kappa 统计评估代谢综合征定义之间的一致性。通过逻辑回归评估代谢综合征和风险因素的患病率以及代谢参数对 8 个月后代谢综合征的预测能力。报告麦克法登伪 R2 作为预测能力的衡量标准,并用赤池信息量准则(Akaike information criterion)评估每个模型的拟合程度。
基线样本中 55.0%为男性,71.6%为西班牙裔,其次是非西班牙裔白人(NHW)(17.3%)和非西班牙裔黑人(NHB)(11.1%),平均年龄为 9.2 岁。代谢综合征的患病率范围为 7.6%-21.4%,西班牙裔儿童的患病率最高(9.0%-24.0%),NHB 儿童的患病率最低(4.0%-14.0%)。与 Ford 等人和 Cook 等人的定义相比,一致性最高(K=0.88),与国际糖尿病联合会的标准相比,一致性最低(K≤0.57)。与 NHW 儿童相比,西班牙裔儿童代谢综合征(OR:1.7;p=0.03)和腰围、HDL-C 和 FPG 风险因素的患病风险更高(p<0.05),而 NHB 儿童的 FPG 风险因素患病风险更高(p≤0.007),血浆甘油三酯风险因素患病风险更低(p=0.002),在多种代谢综合征定义中均如此。在纵向分析中,HDL-C 是西班牙裔和 NHW 儿童代谢综合征的最强独立预测因子(p<0.001 和 p<0.01),而血浆甘油三酯是 NHB 儿童代谢综合征的最强独立预测因子(p<0.05)。
10 岁以下儿童的代谢综合征患病率较高,提出的标准容易受到种族和民族的影响,对某些人群的心血管风险诊断高于其他人群。临床环境中应采取早期预防措施,考虑种族和民族差异,以减轻疾病的发生。